All Reports
Comprehensive Sustainability Reports
Q2 2025 Impact and Sustainability Update to investors
Comprehensive Sustainability Reports
All Reports
Novartis in Society Integrated Report 2024
All Reports
Comprehensive Sustainability Reports
Annual Report 2024 Corporate Governance
Comprehensive Sustainability Reports
All Reports
Thematic / Issue-specific Reports
Impact & Sustainability: Novartis 11th Annual ESG Investor Event
Thematic / Issue-specific Reports
All Reports
Comprehensive Sustainability Reports
Reporting Criteria for Novartis in Society Integrated Report 2024
Comprehensive Sustainability Reports
Governance Documents
Stakeholder Engagement & Transparency
Novartis in Society Integrated Report 2024
Stakeholder Engagement & Transparency
All Reports
Transparency & Accountability Reports
Report on Child Labor Due Diligence in Our Supply Chain 2024
Transparency & Accountability Reports
All Reports
Financial-linked Sustainability Reports
Sustainability-linked bond 2024 report
Financial-linked Sustainability Reports
All Reports
Transparency & Accountability Reports
Novartis SASB Index 2024
Transparency & Accountability Reports
All Reports
Comprehensive Sustainability Reports
Integrated Report 2024
Comprehensive Sustainability Reports
All Reports
Comprehensive Sustainability Reports
Q4 2024 Impact and Sustainability Update
Comprehensive Sustainability Reports
All Reports
Transparency & Accountability Reports
Transparency Act Statement 2024
Transparency & Accountability Reports
All Reports
Comprehensive Sustainability Reports
Novartis in Society Integrated Report 2023
Comprehensive Sustainability Reports
All Reports
Comprehensive Sustainability Reports
Integrated Report 2022
Comprehensive Sustainability Reports
All Reports
Financial-linked Sustainability Reports
Annual Report 2016
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2015
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2011
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2010
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2007
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2006
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2005
Financial-linked Sustainability Reports
Initial Reports
Financial-linked Sustainability Reports
Annual Report 2004
Financial-linked Sustainability Reports
Governance Documents
Human Rights & Social Responsibility
Novartis Position on Medicines for Patients with Rare Diseases
Human Rights & Social Responsibility
Governance Documents
Innovation, Technology & Responsible AI
ESG Index: Innovation
Innovation, Technology & Responsible AI
Governance Documents
Ethics & Integrity
Novartis Position on Falsified Medical Products
Ethics & Integrity
Governance Documents
Human Rights & Social Responsibility
Novartis Position on Responsible Clinical Trials
Human Rights & Social Responsibility
Governance Documents
Human Rights & Social Responsibility
Novartis Commitment to Diversity in Clinical Trials
Human Rights & Social Responsibility
Governance Documents
Ethics & Integrity
Novartis Position on Animal Research
Ethics & Integrity
Governance Documents
Innovation, Technology & Responsible AI
Novartis Position on innovative Biologic Medicines and Biosimilars
Innovation, Technology & Responsible AI
Governance Documents
Stakeholder Engagement & Transparency
Clinical Study Transparency: Clinical Study Registration, Results Reporting and Data Sharing
Stakeholder Engagement & Transparency
Governance Documents
Environment & Climate
Environmental Sustainability
Environment & Climate
Governance Documents
Human Rights & Social Responsibility
Human Rights Commitment Statement
Human Rights & Social Responsibility
Governance Documents
Innovation, Technology & Responsible AI
Novartis Position on innovative Biologic Medicines and Biosimilars
Innovation, Technology & Responsible AI
Governance Documents
Environment & Climate
Novartis Position on Pharmaceuticals in the Environment
Environment & Climate
Governance Documents
Governance & Compliance
Novartis Organizational Structure
Governance & Compliance
Governance Documents
Stakeholder Engagement & Transparency
Novartis Position on Collaborating with Patient Organizations
Stakeholder Engagement & Transparency
Governance Documents
Human Rights & Social Responsibility
ESG Index: Access to medicines
Human Rights & Social Responsibility
Governance Documents
Environment & Climate
Novartis Position on Pharmaceuticals in the Environment
Environment & Climate
Governance Documents
Sustainable Supply Chain
Environmental Sustainability Criteria for Suppliers
Sustainable Supply Chain
Governance Documents
Environment & Climate
Novartis Environmental Sustainability Strategy
Environment & Climate
Governance Documents
Ethics & Integrity
Our Code of Ethics
Ethics & Integrity
Governance Documents
Human Rights & Social Responsibility
Human Rights Commitment Statement
Human Rights & Social Responsibility
All Reports
Transparency & Accountability Reports
Modern Slavery Statement 2024 - Australia, Canada, and United Kingdom
Transparency & Accountability Reports
